\documentclass[11pt,twoside]{article}\makeatletter

\IfFileExists{xcolor.sty}%
  {\RequirePackage{xcolor}}%
  {\RequirePackage{color}}
\usepackage{colortbl}
\usepackage{wrapfig}
\usepackage{ifxetex}
\ifxetex
  \usepackage{fontspec}
  \usepackage{xunicode}
  \catcode`⃥=\active \def⃥{\textbackslash}
  \catcode`❴=\active \def❴{\{}
  \catcode`❵=\active \def❵{\}}
  \def\textJapanese{\fontspec{Noto Sans CJK JP}}
  \def\textChinese{\fontspec{Noto Sans CJK SC}}
  \def\textKorean{\fontspec{Noto Sans CJK KR}}
  \setmonofont{DejaVu Sans Mono}
  
\else
  \IfFileExists{utf8x.def}%
   {\usepackage[utf8x]{inputenc}
      \PrerenderUnicode{–}
    }%
   {\usepackage[utf8]{inputenc}}
  \usepackage[english]{babel}
  \usepackage[T1]{fontenc}
  \usepackage{float}
  \usepackage[]{ucs}
  \uc@dclc{8421}{default}{\textbackslash }
  \uc@dclc{10100}{default}{\{}
  \uc@dclc{10101}{default}{\}}
  \uc@dclc{8491}{default}{\AA{}}
  \uc@dclc{8239}{default}{\,}
  \uc@dclc{20154}{default}{ }
  \uc@dclc{10148}{default}{>}
  \def\textschwa{\rotatebox{-90}{e}}
  \def\textJapanese{}
  \def\textChinese{}
  \IfFileExists{tipa.sty}{\usepackage{tipa}}{}
\fi
\def\exampleFont{\ttfamily\small}
\DeclareTextSymbol{\textpi}{OML}{25}
\usepackage{relsize}
\RequirePackage{array}
\def\@testpach{\@chclass
 \ifnum \@lastchclass=6 \@ne \@chnum \@ne \else
  \ifnum \@lastchclass=7 5 \else
   \ifnum \@lastchclass=8 \tw@ \else
    \ifnum \@lastchclass=9 \thr@@
   \else \z@
   \ifnum \@lastchclass = 10 \else
   \edef\@nextchar{\expandafter\string\@nextchar}%
   \@chnum
   \if \@nextchar c\z@ \else
    \if \@nextchar l\@ne \else
     \if \@nextchar r\tw@ \else
   \z@ \@chclass
   \if\@nextchar |\@ne \else
    \if \@nextchar !6 \else
     \if \@nextchar @7 \else
      \if \@nextchar (8 \else
       \if \@nextchar )9 \else
  10
  \@chnum
  \if \@nextchar m\thr@@\else
   \if \@nextchar p4 \else
    \if \@nextchar b5 \else
   \z@ \@chclass \z@ \@preamerr \z@ \fi \fi \fi \fi
   \fi \fi  \fi  \fi  \fi  \fi  \fi \fi \fi \fi \fi \fi}
\gdef\arraybackslash{\let\\=\@arraycr}
\def\@textsubscript#1{{\m@th\ensuremath{_{\mbox{\fontsize\sf@size\z@#1}}}}}
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\def\abbr{}
\def\corr{}
\def\expan{}
\def\gap{}
\def\orig{}
\def\reg{}
\def\ref{}
\def\sic{}
\def\persName{}\def\name{}
\def\placeName{}
\def\orgName{}
\def\textcal#1{{\fontspec{Lucida Calligraphy}#1}}
\def\textgothic#1{{\fontspec{Lucida Blackletter}#1}}
\def\textlarge#1{{\large #1}}
\def\textoverbar#1{\ensuremath{\overline{#1}}}
\def\textquoted#1{‘#1’}
\def\textsmall#1{{\small #1}}
\def\textsubscript#1{\@textsubscript{\selectfont#1}}
\def\textxi{\ensuremath{\xi}}
\def\titlem{\itshape}
\newenvironment{biblfree}{}{\ifvmode\par\fi }
\newenvironment{bibl}{}{}
\newenvironment{byline}{\vskip6pt\itshape\fontsize{16pt}{18pt}\selectfont}{\par }
\newenvironment{citbibl}{}{\ifvmode\par\fi }
\newenvironment{docAuthor}{\ifvmode\vskip4pt\fontsize{16pt}{18pt}\selectfont\fi\itshape}{\ifvmode\par\fi }
\newenvironment{docDate}{}{\ifvmode\par\fi }
\newenvironment{docImprint}{\vskip 6pt}{\ifvmode\par\fi }
\newenvironment{docTitle}{\vskip6pt\bfseries\fontsize{22pt}{25pt}\selectfont}{\par }
\newenvironment{msHead}{\vskip 6pt}{\par}
\newenvironment{msItem}{\vskip 6pt}{\par}
\newenvironment{rubric}{}{}
\newenvironment{titlePart}{}{\par }

\newcolumntype{L}[1]{){\raggedright\arraybackslash}p{#1}}
\newcolumntype{C}[1]{){\centering\arraybackslash}p{#1}}
\newcolumntype{R}[1]{){\raggedleft\arraybackslash}p{#1}}
\newcolumntype{P}[1]{){\arraybackslash}p{#1}}
\newcolumntype{B}[1]{){\arraybackslash}b{#1}}
\newcolumntype{M}[1]{){\arraybackslash}m{#1}}
\definecolor{label}{gray}{0.75}
\def\unusedattribute#1{\sout{\textcolor{label}{#1}}}
\DeclareRobustCommand*{\xref}{\hyper@normalise\xref@}
\def\xref@#1#2{\hyper@linkurl{#2}{#1}}
\begingroup
\catcode`\_=\active
\gdef_#1{\ensuremath{\sb{\mathrm{#1}}}}
\endgroup
\mathcode`\_=\string"8000
\catcode`\_=12\relax

\usepackage[a4paper,twoside,lmargin=1in,rmargin=1in,tmargin=1in,bmargin=1in,marginparwidth=0.75in]{geometry}
\usepackage{framed}

\definecolor{shadecolor}{gray}{0.95}
\usepackage{longtable}
\usepackage[normalem]{ulem}
\usepackage{fancyvrb}
\usepackage{fancyhdr}
\usepackage{graphicx}
\usepackage{marginnote}

\renewcommand{\@cite}[1]{#1}


\renewcommand*{\marginfont}{\itshape\footnotesize}

\def\Gin@extensions{.pdf,.png,.jpg,.mps,.tif}

  \pagestyle{fancy}

\usepackage[pdftitle={Implant Surface Micro-Design},
 pdfauthor={}]{hyperref}
\hyperbaseurl{}

	 \paperwidth210mm
	 \paperheight297mm
              
\def\@pnumwidth{1.55em}
\def\@tocrmarg {2.55em}
\def\@dotsep{4.5}
\setcounter{tocdepth}{3}
\clubpenalty=8000
\emergencystretch 3em
\hbadness=4000
\hyphenpenalty=400
\pretolerance=750
\tolerance=2000
\vbadness=4000
\widowpenalty=10000

\renewcommand\section{\@startsection {section}{1}{\z@}%
     {-1.75ex \@plus -0.5ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large\bfseries}}
\renewcommand\subsection{\@startsection{subsection}{2}{\z@}%
     {-1.75ex\@plus -0.5ex \@minus- .2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large}}
\renewcommand\subsubsection{\@startsection{subsubsection}{3}{\z@}%
     {-1.5ex\@plus -0.35ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\large}}
\renewcommand\paragraph{\@startsection{paragraph}{4}{\z@}%
     {-1ex \@plus-0.35ex \@minus -0.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\normalsize}}
\renewcommand\subparagraph{\@startsection{subparagraph}{5}{\parindent}%
     {1.5ex \@plus1ex \@minus .2ex}%
     {-1em}%
     {\reset@font\normalsize\bfseries}}


\def\l@section#1#2{\addpenalty{\@secpenalty} \addvspace{1.0em plus 1pt}
 \@tempdima 1.5em \begingroup
 \parindent \z@ \rightskip \@pnumwidth 
 \parfillskip -\@pnumwidth 
 \bfseries \leavevmode #1\hfil \hbox to\@pnumwidth{\hss #2}\par
 \endgroup}
\def\l@subsection{\@dottedtocline{2}{1.5em}{2.3em}}
\def\l@subsubsection{\@dottedtocline{3}{3.8em}{3.2em}}
\def\l@paragraph{\@dottedtocline{4}{7.0em}{4.1em}}
\def\l@subparagraph{\@dottedtocline{5}{10em}{5em}}
\@ifundefined{c@section}{\newcounter{section}}{}
\@ifundefined{c@chapter}{\newcounter{chapter}}{}
\newif\if@mainmatter 
\@mainmattertrue
\def\chaptername{Chapter}
\def\frontmatter{%
  \pagenumbering{roman}
  \def\thechapter{\@roman\c@chapter}
  \def\theHchapter{\roman{chapter}}
  \def\thesection{\@roman\c@section}
  \def\theHsection{\roman{section}}
  \def\@chapapp{}%
}
\def\mainmatter{%
  \cleardoublepage
  \def\thechapter{\@arabic\c@chapter}
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \pagenumbering{arabic}
  \setcounter{secnumdepth}{6}
  \def\@chapapp{\chaptername}%
  \def\theHchapter{\arabic{chapter}}
  \def\thesection{\@arabic\c@section}
  \def\theHsection{\arabic{section}}
}
\def\backmatter{%
  \cleardoublepage
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \setcounter{secnumdepth}{2}
  \def\@chapapp{\appendixname}%
  \def\thechapter{\@Alph\c@chapter}
  \def\theHchapter{\Alph{chapter}}
  \appendix
}
\newenvironment{bibitemlist}[1]{%
   \list{\@biblabel{\@arabic\c@enumiv}}%
       {\settowidth\labelwidth{\@biblabel{#1}}%
        \leftmargin\labelwidth
        \advance\leftmargin\labelsep
        \@openbib@code
        \usecounter{enumiv}%
        \let\p@enumiv\@empty
        \renewcommand\theenumiv{\@arabic\c@enumiv}%
	}%
  \sloppy
  \clubpenalty4000
  \@clubpenalty \clubpenalty
  \widowpenalty4000%
  \sfcode`\.\@m}%
  {\def\@noitemerr
    {\@latex@warning{Empty `bibitemlist' environment}}%
    \endlist}

\def\tableofcontents{\section*{\contentsname}\@starttoc{toc}}
\parskip0pt
\parindent1em
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\newenvironment{reflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemsep}{0pt}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\itshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{sansreflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\itemsep}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\upshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{specHead}[2]%
 {\vspace{20pt}\hrule\vspace{10pt}%
  \phantomsection\label{#1}\markright{#2}%

  \pdfbookmark[2]{#2}{#1}%
  \hspace{-0.75in}{\bfseries\fontsize{16pt}{18pt}\selectfont#2}%
  }{}
      \def\TheFullDate{2014-01-15 (revised: 15 January 2014)}
\def\TheID{\makeatother }
\def\TheDate{2014-01-15}
\title{Implant Surface Micro-Design}
\author{}\makeatletter 
\makeatletter
\newcommand*{\cleartoleftpage}{%
  \clearpage
    \if@twoside
    \ifodd\c@page
      \hbox{}\newpage
      \if@twocolumn
        \hbox{}\newpage
      \fi
    \fi
  \fi
}
\makeatother
\makeatletter
\thispagestyle{empty}
\markright{\@title}\markboth{\@title}{\@author}
\renewcommand\small{\@setfontsize\small{9pt}{11pt}\abovedisplayskip 8.5\p@ plus3\p@ minus4\p@
\belowdisplayskip \abovedisplayskip
\abovedisplayshortskip \z@ plus2\p@
\belowdisplayshortskip 4\p@ plus2\p@ minus2\p@
\def\@listi{\leftmargin\leftmargini
               \topsep 2\p@ plus1\p@ minus1\p@
               \parsep 2\p@ plus\p@ minus\p@
               \itemsep 1pt}
}
\makeatother
\fvset{frame=single,numberblanklines=false,xleftmargin=5mm,xrightmargin=5mm}
\fancyhf{} 
\setlength{\headheight}{14pt}
\fancyhead[LE]{\bfseries\leftmark} 
\fancyhead[RO]{\bfseries\rightmark} 
\fancyfoot[RO]{}
\fancyfoot[CO]{\thepage}
\fancyfoot[LO]{\TheID}
\fancyfoot[LE]{}
\fancyfoot[CE]{\thepage}
\fancyfoot[RE]{\TheID}
\hypersetup{citebordercolor=0.75 0.75 0.75,linkbordercolor=0.75 0.75 0.75,urlbordercolor=0.75 0.75 0.75,bookmarksnumbered=true}
\fancypagestyle{plain}{\fancyhead{}\renewcommand{\headrulewidth}{0pt}}

\date{}
\usepackage{authblk}

\providecommand{\keywords}[1]
{
\footnotesize
  \textbf{\textit{Index terms---}} #1
}

\usepackage{graphicx,xcolor}
\definecolor{GJBlue}{HTML}{273B81}
\definecolor{GJLightBlue}{HTML}{0A9DD9}
\definecolor{GJMediumGrey}{HTML}{6D6E70}
\definecolor{GJLightGrey}{HTML}{929497} 

\renewenvironment{abstract}{%
   \setlength{\parindent}{0pt}\raggedright
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
   \textcolor{GJBlue}{\large\bfseries\abstractname\space}
}{%   
   \vskip8pt
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
}

\usepackage[absolute,overlay]{textpos}

\makeatother 
      \usepackage{lineno}
      \linenumbers
      
\begin{document}

             \author[1]{Dr. Ashu  Sharma}

             \affil[1]{  Sharma Dental Hospital}

\renewcommand\Authands{ and }

\date{\small \em Received: 15 December 2013 Accepted: 4 January 2014 Published: 15 January 2014}

\maketitle


\begin{abstract}
        


The application of implants for dental and orthopedic surgery has increased rapidly within the past few decades. In craniomaxillofacial surgery, different implant systems have been applied, for example, for dental and bone replacement or osteosynthesis plates and screws. These implants may be made of pure titanium or a titanium alloy, usually titaniumaluminum- vanadium (Ti-6Al-4V). The surface can he turned or Machined or a coating may cover the metal base. The reason for treating the implant surface is to obtain maximum boneimplant contact and bone-implant stability and to shorten the healing time for earlier loading. The crucial aspect of pure titanium implants is the development of titanium oxide on the surface. This oxide and other known coatings for implant material do not have high wear resistance. This article thus aims to review Implant Surface Micro-design its rationale, various surface?s physical and chemical properties, different types of implant surface treatments, optimum roughness of oxidized implants and controversies associated with various implant topographies. The recent advances like nanotechnology are also included.

\end{abstract}


\keywords{implants, implant topography, implant surface micro-design, implant surface treatments.}

\begin{textblock*}{18cm}(1cm,1cm) % {block width} (coords) 
\textcolor{GJBlue}{\LARGE Global Journals \LaTeX\ JournalKaleidoscope\texttrademark}
\end{textblock*}

\begin{textblock*}{18cm}(1.4cm,1.5cm) % {block width} (coords) 
\textcolor{GJBlue}{\footnotesize \\ Artificial Intelligence formulated this projection for compatibility purposes from the original article published at Global Journals. However, this technology is currently in beta. \emph{Therefore, kindly ignore odd layouts, missed formulae, text, tables, or figures.}}
\end{textblock*}


\let\tabcellsep& 	 	 		 
\section[{Introduction}]{Introduction}\par
he success and predictability of osseointegrated dental implants have forever changed the philosophy and practice of dentistry and, perhaps more than any other specialty, Prosthodontics has changed dramatically. In the late 1950's, Per-Ingvar Branemark, a Swedish professor in anatomy studying blood circulation in bone and marrow, developed through a serendipitous finding in the history of medicine: he predictably achieved an intimate bone-toimplant apposition that offered sufficient strength to cope with load transfer. He called the phenomenon "osseointegration".. Since that time, millions of patients have been treated worldwide using this technique. The implants used sometimes had different geometries and surface characteristics. A key element in the reaction of hard and soft tissues to an implant involves the implant's surface characteristics, that is, the chemical and physical properties. Quest continued for a material with a surface property which enhances bone apposition at the implant surface in an osteoconductive manner. The quest was for a biocompatible if not bioactive surfaces, achieved through additive or subtractive process. Titanium, preferably commercially pure titanium, became the standard for endosseous implants. Actually titanium is a very reactive material that would not become integrated with tissues. However, its instantaneous surface oxidation creates a passivation layer of titanium oxides, which have ceramic-like properties, making it very compatible with tissues. 
\section[{II.}]{II.} 
\section[{Rationale for a Dynamic Implant Surface}]{Rationale for a Dynamic Implant Surface}\par
Oral implant is an alloplastic material or device that is surgically placed in to the oral tissue beneath the mucosal or periosteal layer or within the bone for functional, therapeutic, or esthetic purposes \hyperref[b0]{1} . More needs to be known about the optimal situation of the connection between an artificial material and the tissues-what type of material that gives the best tissue response and what type of surface is preferred by the bone cells or the cells in the soft tissue. If this is known, the response of the bone or soft tissue can be predicted when the implants are installed into the jaws. There is some information and understanding of the effect of design and toxicology of the implants, surgery techniques, effect of movement of the implant during the healing period and biodegradation. Understanding is lacking, however, of the relationship between the events that occur at the implant surface and the effect the implant material has in the tissue and the biocompatibility of the material \hyperref[b1]{2} .\par
a) The bone-implant interface Bone tissue is a living organ, which can be described as a natural composite composed of an organic matrix strengthened by an inorganic calcium phosphate (CaP) phase. The extracellular organic matrix (ECM) of bone consists of 90\% collagenous proteins and 10\% non-collagenous proteins. Regarding the inorganic component, the most abundant mineral phase in human bone is carbonate rich hydroxyapatite (with a carbonate content between 4\% and 8\%) \hyperref[b2]{3} .\par
When an implant is installed in a jaw, a series of reactions take place on the implant surface. The implant is exposed to a series of different ions, to polysaccharides, carbohydrates and proteins as well as to such cells as chondroblasts, fibroblasts and osteob-lasts that react with the surface (Figure  {\ref :}1 and 1a) \hyperref[b1]{2,}\hyperref[b2]{3} . The initial reactions between the tissue constituents and the implant surface govern the further reactions and determine the biological activity of the surface and the further cell responses to the surface. This tissue response depends on the nature of the surface and its chemical properties, which influences the nature of the subsequent composition of the protein film that adsorbs onto the material \hyperref[b3]{[4]}\hyperref[b4]{[5]}\hyperref[b5]{[6]}\hyperref[b6]{[7]} . this further strongly influences the cell responses on the surfaces.\par
Figure  {\ref 1} : After implantation, the biomaterial is exposed to a series of different tissue constituents that react with the surface. The type of reaction that occurs probably influences the further cell reactions and finally the tissuebiomaterial connection. Ig: immunoglobulins Figure  {\ref 1}(a) : Schematic representation of events consecutively taking place at the titanium surface after implantation into living bone tissue. Water binds to the surface, followed by incorporation of hydrated ions, adsorption and desorption of proteins, eventually leading to cell attachment. After differentiation, mature osteoblasts produce the extracellular matrix (ECM) b) Osseo-integration versus Osseo-coalescence\par
The term osseointegration largely refers to the physical integration or mechanical fixation of an implant in bone. The interlocking provides mechanical resistance to forces such as shear experienced in "pull-out" and "torque-out". With purely physical interaction, however, the interface would not be able to withstand even moderate tensile forces. The term osseocoalescence has been proposed to refer specifically to chemical integration of implants in bone tissue. The term applies to surface reactive materials, such as calcium phosphates and bioactive glasses, which undergo reactions that lead to chemical bonding between bone and biomaterial. With these materials, the tissues effectively coalesce with the implant \hyperref[b7]{8} . 
\section[{III.}]{III.} 
\section[{Physical Properties}]{Physical Properties}\par
Several authors have discussed the dimension of the ideal roughness that would provide increased retention and an improved bone response. The roughness can be considered on different levels: macrostructural, microstructural and ultrastructural, and roughness on these different levels probably has different effects on the living tissues. It has been established in the literature based on several studies that, to gain complete growth of bone into a material's irregularities, these need to be at least 100 µm in size. Growth of bone into cavities or pores of this size will give a mechanical interlocking of the material with bone. This was demonstrated by Bobyn et al. in studying cobaltbased alloys with pore sizes of 50-400 µm \hyperref[b8]{9} , Bone ingrowth was also observed by Clemow et al. when this group studied porous coated Ti\&l,V femoral implants with pore sizes ranging from 175 to 235 µm \hyperref[b9]{10} . 
\section[{a) Surface Microstructure}]{a) Surface Microstructure}\par
This can vary considerably depending on the surface treatment of the implant. Variation of the surface microstructure has been reported to influence the stress distribution, retention of the implants in bone and cell responses to the implant surface. The implants with rough surfaces have improved bone response, with bone trabeculae growing in a perpendicular direction to the implant surface. An improved retention in bone has also previously been reported after implantation of rough-surfaced implants \hyperref[b1]{2} .\par
Surface roughness on a smaller scale was, however, found to be important for integration of the bone with the implant surface \hyperref[b10]{11} . Although surface roughness on a micrometer scale gives some retention due to bone in growth, in vitro cell studies indicate that this property of the surface influences the function of the cells, the matrix deposition and the mineralization \hyperref[b11]{12} . Cells seem to be sensitive to microtopography and appear to be able to use the morphology of the material for orientation and migration \hyperref[b12]{13} . The maturation of the cells also affects the response to the surface roughness, which is in agreement with earlier observations that indicated that chondrocytes are affected differently by local factors such as vitamin D and transforming growth factor p depending on the stages of maturation of the cells \hyperref[b13]{14,}\hyperref[b14]{15} . Microtopography may therefore be one factor that influences the differentiation of mesenchymal cells into fibroblasts, chondrocytes or osteoblasts. Based on these studies, it can be hypothesized that osteogenesis may be favored by vascular in growth, whereas a limited vascular in growth may induce chondrogenesis. Figures: 2 and   The ideal surface roughness for bone implants on a micrometer scale probably depends on the distribution of cortical or cancellous bone and on the level of loading to the implants. \hyperref[b1]{2} The rugofile bone cells recognizes the surface prepared by the course particle, as a smooth surface, whereas the 25-pm particles creates a rough surface that is identified by the osteoblasts  Osteoblasts respond to microarchitectural features of their substrate. On smooth surfaces (tissue culture plastic, tissue culture glass, and titanium), the cells attach and proliferate but they exhibit relatively low expression of differentiation markers in monolayer cultures, even when confluent. When grown on microrough Ti surfaces with an average roughness of 4-7 ?m, proliferation is reduced but differentiation is enhanced and in some cases,as it is synergistic with the effects of surface microtopography. In addition, cells on microrough Ti substrates form hydroxyapatite in a manner that is more typical of bone than do cells cultured on smooth surfaces. Osteoblasts also respond to growth factors and cytokines in a surface-dependent manner. On rougher surfaces, the effects of regulatory factors like 1?, 25(OH) 2 D 3 or 17?-estradiol are enhanced. When osteoblasts are grown on surfaces with chemistries or micro architectures that reduce cell attachment and proliferation, and enhance differentiation, the cells tend to increase production of factors like TGF ?1 that promote osteogenesis while decreasing osteoclastic activity. Thus, on microrough Ti surface, osteoblasts create a microenvironment conducive to new bone formation \hyperref[b15]{16} . Figure:  Although micro-roughness seems to be an important characteristic for tissue response to biomaterials, there are also observations that indicate a biological response to irregularities on the nanometer level. Larsson et al. studied the biological effect of changing the oxide thickness of titanium implants from an electropolished level, to thick oxide layers formed by anodization. By this treatment the surface changes from an amorphous metal surface with a noncrystalline oxide to a polycrystalline metal surface with a crystalline oxide layer \hyperref[b16]{17} .\par
Analysis of these surfaces at a high resolution level demonstrated that the new surface was heterogeneous with mainly smooth areas of thick oxide but separated with porous regions on a nanometer level. This observation of an increased roughness after anodization of titanium was in line with earlier transmission electron microscopic studies demonstrating increased pore sizes with increased oxide thickness \hyperref[b17]{18} .\par
Implants with this thick, heterogeneous oxide seemed to have a slightly improved response in bone, particularly in the first weeks after implantation. c) Smooth versus Rough Surfaces Surface quality of an oral implant can be subdivided in to mechanical, topographic, and physicchemical properties \hyperref[b18]{19} . Surface topography is characteristic of the preparation process. Variations in the roughness and porosity can be categorized in function of the surfacing process. The current state of information regarding implant surface topography has provided clinicians with confusing options. Machined implants are not smooth, and not all rough implant surfaces are equivalent. Surfaces often are identified by the method of manufacture and not the resultant surface.\par
Rough surfaces can be divided into three levels depending on the scale of the features: macro-, microand nano-sized topologies. The macro level is defined for topographical features as being in the range of millimeters to tens of microns \hyperref[b19]{20} . This scale is directly related to implant geometry, with threaded screw and macro porous surface treatments giving surface roughness of more than 10?m. Numerous reports have shown that both the early fixation and long-term mechanical stability of the prosthesis can be improved by a high roughness profile compared to smooth surfaces \hyperref[b20]{21} .\par
The high roughness resulted in mechanical interlocking between the implant surface and bone on growth. However, a major risk with high surface roughness may be an increase in peri-implantitis as well as an increase in ionic leakage. A moderate roughness of 1-2?m may limit these two parameters \hyperref[b21]{22} . The microtopographic profile of dental implants is defined for surface roughness as being in the range of 1-10?m.\par
IV. 
\section[{Chemical Properties a) The surface chemistry of the implants}]{Chemical Properties a) The surface chemistry of the implants}\par
The chemical properties of the biomaterial surface play an important role for the tissue responses elicited by the material. This is at least one main reason why the tissues responds differently to different materials. \hyperref[b1]{2} A material with a surface that is accepted by the tissue seems to exhibit improved integration with bone, either due to passive growth, leading to a tight connection between implants and bone, or by stimulation that probably leads to a bone-implant bonding. This is probably the case with the two main materials used in dental implants, hydroxyapatite and J titanium. \hyperref[b1]{2} The calcified parts of the bone consists of hydroxyapatite (or rather carbonated apatite), and introducing this substance as an implant material often gives favorable responses in the bone. \hyperref[b22]{23} The biological effects of modifying the biomaterial surface have also been elaborated \hyperref[b23]{[24]}\hyperref[b24]{[25]} . In an attempt to study the effect of the oxide layer of titanium on calcium-phosphate precipitation, titanium-dioxide (TiO2) and powder of oxidized and nonoxidized titanium were introduced into an in vitro nucleation test system \hyperref[b23]{24} . In this system they found that titanium powder enhances calcium phosphate nucleation only after prolonged preincubation in an aqueous buffer, or after autoclaving. These treatments enhance the growth of the oxide layer. This observation indicated that the oxide content, or structure, is required for titanium to act as a nucleation substrate. Even more effective nucleation was observed when pure TiO2 was used as a nucleation substrate. The nucleation capacity and formation of calcium phosphate precipitates is related to the biocompatibility of titanium, and enhanced nucleation capacity may indicate improved biocompatibility. \hyperref[b1]{2} The biological activity of the TiO 2 probably also influences the protein adsorption to titanium. In an in vitro study, serum proteins seemed to adsorb to titanium dioxide by the same mechanisms as to hydroxyapatite through calcium binding \hyperref[b23]{24} . The surface characteristics of TiO2 probably change from an anionic to a cationic state by the adsorption of calcium to the surface. This will subsequently increase its ability to adsorb acidic macromolecules, such as albumin, a property demonstrated for hydroxyapatite \hyperref[b25]{[26]}\hyperref[b26]{[27]} .\par
Fluoride ions have documented activity in bone. This element is known to form fluoridated hydroxyapatite or fluorapatite with improved crystallinity and better resistance to dissolution than hydroxyapatite \hyperref[b27]{28} . Fluoride also enhances the incorporation of newly formed collagen into the bone matrix and increases the rate of seeding of apatite crystals as well as increasing trabecular bone density and stimulating osteoprogenitor cells number in vitro  {\ref 29,30.}    
\section[{Diferent Types of Implant Surface Treatments}]{Diferent Types of Implant Surface Treatments}\par
The desired implant surface can be achieved by addition of material over the surface, removal of material from the surface or modification of the surface material. Some of the examples are: I. Addition of material -Titanium plasma spray (TPS, TiO2); coating with hydroxyapatite (HA).\par
II. Removal of material -Particle jets and/or acid etching III. Modification of material -The implant surface can be modified without either adding or removing material. (Electron beam, thermal treatment, laser treatment, and ion implantation) a) Addition of Material (Additive Methods)\par
Chemical substances are successfully added over the surface. Some of the materials used for this purpose include: VI. 
\section[{Additive Methods of Surface Treatment a) Hydroxyapatite coating}]{Additive Methods of Surface Treatment a) Hydroxyapatite coating}\par
Hydroxyapatite is a calcium phosphate ceramic that is an osteophilic, osteoconductive, bioactive coating, which is totally biocompatible and becomes an integral part of living bone tissue. Hydroxyapatites and tricalcium phosphates have an excellent grade of acceptance, and these materials may be more rapidly incorporated in bone than commercially pure titanium. Hydroxyapatite coating over titanium has enjoyed a rapid growth because of its inherent biomaterial properties that some consider an advantage over uncoated surgical titanium. Hydroxyapatite (HA) coating has become popular for load bearing dental implants because it elicits a faster bony adaptation, absence of fibrous tissue seams, firmer implant bone attachment, reduced healing time, increased tolerance of surgical inaccuracies, and inhibition of ion release \hyperref[b30]{31} .\par
The first clinical use of hydroxyapatite (HA) as a coating on dental implants began in February 1984, with the results showing many benefits over the no coated implants31. Later, many researchers conducted studies and obtained promising results.\par
Contemporary plasma-sprayed hydroxyapatite (HA) coatings with high crystalline content are much more resistant to in vivo degradation than HA coatings of a decade ago but reportedly exhibit reduced wettability, which could potentially negatively affect tissue adhesion and long-term clinical outcome.\par
Bone morphogenetic proteins (BMP s) play a crucial role in cell ingrowth and differentiation in a variety of cell types, including osteoblasts \hyperref[b31]{32} . Because of their beneficial effects, BMP s have been used to accelerate healing after implant placement. Apatite is considered a suitable carrier of BMP-2 \hyperref[b32]{33} and the incorporation of BMP-2 into the apatite layer of a titanium implant may enhance its osteoinductive properties. i. 
\section[{Methods of HA Coating}]{Methods of HA Coating}\par
Conventional plasma spraying, flame spraying, and chemical techniques have all been investigated as techniques for producing a thinner HA coating on a metal substrate. The bond formed between HA coatings and the metallic substrate by the spraying method, formed primarily through mechanical interlocking, is not strong enough. Additionally, the spraying method is unsatisfactory for applying a thinner, uniform HA coating on implants because of their complicated shapes. On the other hand, electrochemical methods, electrop-0horetic techniques in particular, seem attractive for forming HA coatings on titanium implants with complicated shapes. However, the bond between the coating and the metal substrate is significantly weak. Magnetron sputter coating and Ion Beam sputtering techniques for coating HA on implant surfaces have been tried with varying rates of success. Hydroxyapatite can be coated by plasma spraying. In this technique, powdered crystalline hydroxyapatite is introduced and melted by the hot, high velocity region of a plasma gun and propelled onto the metal implant as a partially melted ceramic. b) Plasma Sprayed Titanium Hahn and Palich (1970) first developed titanium surfaces by plasma spray techniques and reported an enhanced bone ingrowth in those implants. The plasma sprayed titanium surfaces exhibit a porous surface with macro irregularities \hyperref[b33]{34} . 
\section[{i. Macro-irregularities}]{i. Macro-irregularities}\par
Macro-irregularities in an implant include macroscopic threads, fenestrations, pores, grooves, steps, threads, or other surface irregularities that are visible. The idea is to create mechanical interlocking between implant and bone at the macro level.\par
ii. Method of Plasma spraying Powdered Titanium is melted at a temperature of 15,000 degrees and is sprayed on to the surfaces of the implant at a very high velocity of 600 m/sec through argon plasma associated with a nozzle. The diameters of the sprayed particles are around .04 to .05mm thickness. When observed microscopically the coatings show round or irregular pores that are interconnected with each other. The surface of the implants where they condense and fuse together, forming a film about 30 ?m thick. The thickness must reach 40-50 ?m to be uniform. The resulting TPS coating has an average roughness of around 7 ?m, which increases the surface area of the implant. c) Anodic Spark Deposition Anodic spark deposition techniques have been effectively applied to achieve a microporous morphology on metals. Recently, a new electrochemical process has been developed to improve further the mineralization potential, mechanical stability, and corrosion resistance of the ceramic coating obtained with anodic spark deposition. Electrochemically treated titanium showed promising results and was able to introduce substantial improvements in achieving fast and stable osseointegration of implants in osteopenic sheep bone \hyperref[b34]{35} . 
\section[{d) Biologic Coatings}]{d) Biologic Coatings}\par
Puleo and Nanci (1999) emphasized the importance of biochemical methods of surface modification as an alternative or adjunct to morphologic approaches. Biochemical methods are aimed at control of the tissueimplant interface by the immobilization and/or delivery of proteins, enzymes, or peptides for the purpose of inducing specific cell and tissue responses. They rely on current understanding of the biology and biochemistry of cellular function and differentiation and on suitable surface modification techniques \hyperref[b35]{36} . e) Bio-molecules i.\par
Laminins \hyperref[b36]{37} Laminins are major proteins in the basal lamina, a protein network foundation for most cells and organs. They are an important and biologically active part of the basal lamina, influencing cell differentiation, migration, adhesion as well as phenotype and survival.\par
ii.\par
Fibronectin \hyperref[b36]{37} Fibronectin is a high-molecular weight (\textasciitilde 440 kDa) extracellular matrix glycoprotein that binds to membrane-spanning receptor proteins called integrins.\par
In addition to integrins, fibronectin also binds extracellular matrix components such as collagen, fibrin and heparan sulfate proteoglycans.\par
It is involved in cell adhesion, growth, migration and differentiation. Cellular fibronectin is assembled into the extracellular matrix, an insoluble network that separates and supports the organs and tissues of an organism.\par
iii. 
\section[{Vitronectin}]{Vitronectin}\par
Vitronectin is an abundant glycoprotein found in serum the extracellular matrix and promotes cell adhesion and spreading.\par
Vitronectin serves to regulate proteolysis initiated by plasminogen activation. Additionally Vitronectin is a component of platelets and is thus involved in hemostasis. Vitronectin contains an RGD sequence which is a binding site for membrane bound integrins, e.g. the Vitronectin receptor, which serve to anchor cells to the extra cellular matrix. iv. 
\section[{RhBMP-2}]{RhBMP-2}\par
BMP's are Bone morphogenetic proteins. They are members of -growth and differentiation protein family. They are homodimeric, glycosylated proteins that are highly conserved across species. They are found to be osteoinductive in animals and humans.\par
They are supposed to promote bone induction by increasing Chemotaxis and increasing the proliferation and differentiation of bone forming cells from undifferentiated mesenchymal cells.\par
They induce the formation of both trabecular and woven bone. The formed bone remodels based on the demand at the particular site. The delivery of BMPs is aimed at local administration, which is in favor for coating the implant surfaces. v. 
\section[{Bio molecules and Implants}]{Bio molecules and Implants}\par
The proportions of these biologic molecules and the presence of other lesser-known components seem to vary with the anatomic location and specific function of the individual basement membrane. Ultra structural data provided by Swope and James (1981)  indicate that hemidesmosomes formed on Vitallium Volume XIV Issue IV Version I Year ( ) J implants in monkeys after 2 days and became well established after 3 days \hyperref[b37]{38} .\par
However, more recently published data dispute these findings, indicating that hemidesmosomal contacts were found only on apatite and polystyrene substrates.\par
vi. 
\section[{Amino acid sequence RGD}]{Amino acid sequence RGD}\par
In a goat femur wound chamber model, Bernhardt et al. (  {\ref 2005}) compared bone-to-implant contact on uncoated titanium implant surfaces with RGD peptide-coated surfaces. After 5 and 12 weeks of healing, no significant effect of RGD coating on the mean bone-to-implant contact percentages was observed \hyperref[b38]{39} . These results contradict the findings of  
\section[{Schliephake et al. (2005b}]{Schliephake et al. (2005b}\par
) compared, in the mandible of dogs, machined titanium implant surfaces (Ti) with RGD-coated implant surfaces. RGD coatings were achieved either with low RGD concentrations (100 m mol/ml) (RGD low') or with high RGD concentrations (1000 m mol/ml) (RGD high). After 1 month of healing, bone-to-implant contact was significantly higher for RGD high compared with Ti. After 3 months of healing, boneto-implant contact was significantly higher for RGD high and for RGD low compared with Ti \hyperref[b39]{40} .\par
vii. 
\section[{Collagen and collagen mimetic peptides}]{Collagen and collagen mimetic peptides}\par
The in vivo osteoconductive potential of type I collagen, type III collagen and collagen mimetic peptide sequences as coating for titanium implants was investigated in the publications of Rammelt et al.  (2004,2006,2007)  \hyperref[b38]{[39]}\hyperref[b39]{[40]}\hyperref[b40]{[41]}\hyperref[b41]{[42]} .\par
In the proximal tibial metaphysis of rats, Reyes et al. (2007) compared the mechanical anchorage as well as bone-to-implant contact of machined c.p.titanium implant surfaces (Ti)with either bovine type I collagen (Col-I) or glycine-phenyl alanine-hydroxy proline-glycine-glutamate-arginine (GFOGER; a collagen mimetic peptide sequence)-coated implant surfaces. After 4 weeks of healing, the mean pull-out forces were around 35N for GFOGER, 20N for ColI and 35N for Ti. GFOGER was statistically higher compared with ColI or Ti, but the values for Col I were not statistically higher compared with Ti. The authors concluded that both coatings (GFOGER and ColI) enhanced bone repair and implant integration. viii. 
\section[{Collagen composite coating with CaP}]{Collagen composite coating with CaP}\par
In the mandible of dogs, Schliephake et al. (  {\ref 2003}) compared bone-to-implant contact between titanium alloy implants with a polished surface (Ti), collagen-coated (Col), mineralized (hydroxyapatite) collagen-coated (Col/HA), sequentially hydroxyapatitecollagen-coated (Col/sew HA) and hydroxyapatitecoated titanium surfaces (HA). Animals were sacrificed after 1 and 3 months of healing. No significant differences in the mean bone-to-implant contact between the various implant surfaces were observed in cortical as well as in cancellous bone after 1 and 3 months of implantation \hyperref[b42]{43} . ix. 
\section[{Growth factor coatings}]{Growth factor coatings}\par
Growth factors are signaling proteins that promote replication, differentiation, protein synthesis and /or migration of appropriate cell types. In case of endosseous titanium implants, an enhanced proliferation and differentiation of undifferentiated mesenchymal cells osteoprogenitor cells and preosteoblasts into osteoblasts may enhance bone healing (Chappard et al.1999)  \hyperref[b43]{44} .\par
Therefore, the rational to coat titanium implants with locally acting growth factors is the assumption that the release of these growth factors might improve the remodeling process at the bone-implant interface, leading to enhanced bone response (De Jonge et al. 2008)  {\ref 45.} x. 
\section[{Bone Morphogenic Proteins}]{Bone Morphogenic Proteins}\par
A particular class of growth factors, BMPs, has shown considerable potential to stimulate bone formation both in extra skeletal sites (Yamazaki et al.  1996; Yoshida et al. 1998)  While BMP-2 is used more commonly, BMP-4 is also considered as a candidate growth factor that might improve the remodeling process at the bone-implant interface (Stadlinger et  xii. 
\section[{Bone-like coatings}]{Bone-like coatings}\par
A method to self-assemble and mineralize collagen gel and to precoat a bone-like layer of J mineralized collagen immobilized on titanium implant surfaces has been demonstrated. The mineralized layer was found to promote cellular activity, indicating potential for more efficient bone remodeling at the implanttissue interface. This may promote and/or accelerate osseointegration \hyperref[b57]{58} . 
\section[{VII.}]{VII.}\par
Removal of Material (Subtractive Methods)\par
Implant Surfaces can be roughened by various material removing techniques. Of which the most common methods are:\par
1. Sandblasting. 2. Acid etching. 
\section[{Machining. a) Machining}]{Machining. a) Machining}\par
The machining of Cp titanium imparts a surface roughness that is distinct from smooth or polished surfaces. The machining method is an important determinant of the resulting surface. Different surfaces are imparted by machining or subsequent modification. Electro polishing of machined components can further reduce variations measured at the surface, but such surfaces are not well osseointegrated. Creating topographic variation from the mean surface plane can be achieved by abrasion (TiO2 blasting or soluble/resorbable blasting materials [S/RBM]), blasting, blasting and etching (alumina oxide and H2SO4/HCl), anodizing, cold working (dimpling), and different chemical etching methods (H2SO4/HCl)59-61. Bone to implant contact is one of the important factors for osseointegration. Bone to implant contact is higher for osteotite surfaces when compared to machined surfaces \hyperref[b62]{62} . 
\section[{b) Grit Blasting}]{b) Grit Blasting}\par
Another approach for roughening the titanium surface consists in blasting the implants with hard ceramic particles. The ceramic particles are projected through a nozzle at high velocity by means of compressed air. Depending on the size of the ceramic particles, different surface roughnesses can be produced on titanium implants. The blasting material should be chemically stable, biocompatible and should not hamper the osseointegration of the titanium implants. Various ceramic particles have been used, such as alumina, titanium oxide and calcium phosphate particles. Alumina (Al2O3) is frequently used as a blasting material and produces surface roughness varying with the granulometry of the blasting media. However, the blasting material is often embedded into the implant surface and residue remains even after ultrasonic cleaning, acid passivation and sterilization. Alumina is insoluble in acid and is thus hard to remove from the titanium surface. In some cases, these particles have been released into the surrounding tissues and have interfered with the osseointegration of the implants. Moreover, this chemical heterogeneity of the implant surface may decrease the excellent corrosion resistance of titanium in a physiological environment \hyperref[b63]{63} . 
\section[{c) Acid-etching}]{c) Acid-etching}\par
Etching with strong acids such as HCl, H2SO4, HNO3 and HF is another method for roughening titanium dental implants.\par
Acid etching produces micro pits on titanium surfaces with sizes ranging from 0.5 to 2nm in diameter. \hyperref[b64]{64} Acid-Immersion of titanium implants for several minutes in a mixture of concentrated HCl and H2SO4 heated above100 ?C (dual acid-etching) is employed to produce a micro rough surface. This type of surface promotes rapid osseointegration while maintaining long-term success over 3 years  {\ref 65.} Enhanced bony anchorage was noted to dual acidetched implants as compared to machined implants \hyperref[b66]{66} .\par
Acid-etched implants showed significantly higher mineral apposition rates compared to acidetched, phosphate coated implants \hyperref[b67]{67} . d) Sand Blasted and Acid etched (SLA) surface Among the various techniques to produce a micro rough titanium surface, the combination of sand blasting and acid etching can be used. These surfaces showed enhanced bone apposition in histomorphometric studies, and higher torque values in biomechanical testing. Based on these experimental studies, clinical studies were initiated to load SLA implants after a reduced healing period of only 6 weeks. The clinical examination up to 3 years demonstrated favorable results, with success rates around 99\%  {\ref 68.} e) Chemically Modified SLA Surface: SLActive SLActive is based on the scientifically proven SLAR topography (M. de Wild 2004.). In addition, it has a fundamentally improved surface chemistry. The chemically active, hydrophilic SLActive surface promotes the initial healing reaction, allowing for direct cell interaction at the initial stage of the osseointegration process. Bone formation is immediately initiated resulting in earlier secondary stability and reducing the critical dip. D.Buser et al studied the modified SLA surface produced by rinsing under N2 protection and storing in an isotonic NaCl solution. They demonstrated that the modSLA surface promoted enhanced bone apposition during early stages of bone regeneration \hyperref[b69]{69} .\par
Michael M. Bornstein et al showed that Dental implants with a mod SLA surface (SLActive) demonstrated statistically significant differences for probing depths and clinical attachment level values compared to the historic control group, with the mod SLA surface implants having overall lower probing depths and clinical attachment level scores \hyperref[b70]{70} . Figure -9. Modification of Material a) Ion Implantation CO ion implantation is a new surface treatment designed to improve implant bone integration by modifying the chemical structure of the implant surface at the atomic level without adding or removing material. This is a high vacuum physical technique (<10-4Pa) in which the surface of a material is bombarded with previously selected and accelerated ions that become integrated or implanted within the outer atomic layers of the surface, thereby modifying the physicochemical properties. A study showed improved percentage BIC values for implants with ion-implanted surfaces in comparison to Diamond like Carbon coating and machined controls. Furthermore, bone integration appeared to be accelerated in the ion implantation group \hyperref[b71]{71} . 
\section[{b) Optimum Roughness}]{b) Optimum Roughness}\par
The topography of rough surfaces is characterized by different surface roughness parameters (Ra, Rq, Rt, Rsk, Rku, ?q, or ?q, in 3D or 3D mode). Hansson described that an average surface roughness Ra (filtering 50x50 µm) of about 1.5 µm gave the strongest fixation for a bone-metal interface. If the implants are smoother or rougher than this, the anchorage between bone and implant decreases.\par
A typical measure of implant surface roughness is the Ra value: the arithmetic mean value of the surface departures from the mean plane. Unfortunately, surfaces may have very different morphologies and still share a common Ra value. It is clear that height descriptors alone do not adequately describe surface roughness. More recently, the average peak spacing (Sa) has been associated with implant behavior. There is enough evidence for the positive relationship between surface roughness and increased bone to implant contact (BIC)  {\ref 72.} c) Optimal Surface Properties Surface properties of implants directly influence bone responses. Thus, irrespective of the surface modification technology used, detailed surface characterization of an implant is important. Based on the bone response in the present study, which was expressed as a function of quantitative changes in the surface oxide properties, the following appear to be the optimum surface properties of oxidized implants:\par
? The optimal oxide thickness of a porous surface structure appeared to be in the range of 1,000 to 5,000 nm. ? An optimum porosity of open pores is in the range of 19\% to 30\%, (i.e.) approximately 24\%; with a pore size of 2.0 ?m. ? Surface roughness values of 0.7 to 1.0 ?m for Sa, 0.9 to 1.4 ?m for Sq, and 27\% to 46\% for Sdr seemed to be optimum. ? TiO2 in a crystalline phase seemed to be optimal \hyperref[b73]{73} . 
\section[{d) Controversies}]{d) Controversies}\par
With Respect To Implant Topographies Machined titanium surfaces have been reported to favor fibroblastic growth, migration, and spread, and therefore were considered favorable for formation of peri-implant soft tissue. On the other hand, because of the increased proliferative activity of fibroblasts on machined surfaces, fibrous capsules or connective tissue overgrowth can form, compromising local blood supply and leading to failure of the implant to integrate with the soft tissue. To overcome this problem, rough Rough titanium surfaces have been reported to improve attachment and decrease growth and spread of fibroblasts. However, a diminished growth of fibroblasts on rough titanium surfaces can result in the formation of a thin connective tissue that will not be capable of supporting surrounding tissue structures. In addition, rough implant surfaces have been reported to be especially prone to peri-implant infection and seem also to attract inflammatory cells.\par
Another suggested titanium surface comprises grooved topography, which has been demonstrated to favor the orientation and alignment of fibroblasts and claimed in several studies to be appropriate for the establishment of an organized connective tissue structure around the implant. However, the exact topographic configurations of grooved titanium surfaces that are appropriate for the in vivo establishment of longterm stable and overall optimal peri-implant soft tissue conditions are still largely unknown.\par
There is a lack of knowledge about the ideal implant surface characteristics that lead to the establishment of optimal connective tissue and attachment around titanium implants. The acid-etching and blasting methods generally do not change the main compositional surface elements of the titanium, which consist mainly of titanium and oxygen, but rather the surface morphology/topography and consequently surface roughness, two action mechanisms of osseointegration of oxidized implants have been proposed: 1) mechanical interlocking through bone growth in pores and 2) biochemical bonding \hyperref[b75]{[74]}\hyperref[b76]{[75]} . 
\section[{e) Surface roughness at the nano scale level}]{e) Surface roughness at the nano scale level}\par
The chemistry and roughness of implant surfaces play a major role in the biological events that follow implantation. Nevertheless, surfaces are often developed using an empirical approach with in vitro and in vivo tests. Most of the surfaces currently available have random topography with a wide range of thicknesses, from nanometers to millimeters \hyperref[b77]{76} .\par
The exact biological role of these features is unknown because of the absence of standardized surfaces with repetitive topography at the nano-sized level (e.g. pits with fixed diameters and depth, lanes with controlled profiles). Such controlled or standardized surfaces might help to understand the interactions between specific proteins and cells. These standardized surfaces might also promote early bone apposition on the implants.\par
Only a few studies have reported modifications to the roughness as well as the chemistry at the nanometer scale in a reproducible manner. Most of these attempts have used processing methods from the electronic industry such lithography and surface laserpitting.\par
These nanometer structures may also give the cells positive guidance by means of the selective attachment of osteoblasts to the implant surface. This selective attachment process might result in the improvement of initial healing around dental implants22. f) Re-Osseo integration Persson et al (2001) evaluated reosseointegration of SLA (Sandblasted and acid etched) and turned implants in dogs. They found that reosseointegration was substantial for implants with SLA surfaces but only minimal for exposed smooth (turned) surfaces. Reosseointegration (BIC) at SLA surfaces averaged 84\% compared to 22\% at turned implant surfaces \hyperref[b78]{77} . 
\section[{IX.}]{IX.} 
\section[{Recent Innovations and Future Directions a) Nanotechnology}]{Recent Innovations and Future Directions a) Nanotechnology}\par
Nanotechnology is the engineering of functional systems at the molecular scale. Materials reduced to the nanoscale can show different properties compared to what they exhibit on a macro scale, enabling unique applications. For instance, opaque substances become transparent (copper); stable materials turn combustible (aluminum); insoluble materials become soluble (gold). A material such as gold, which is chemically inert at normal scales, can serve as a potent chemical catalyst at nanoscale. Much of the fascination with nanotechnology stems from these quantum and surface phenomena that matter exhibits at the nanoscale.\par
Nanotechnology involves materials that have a nano-sized topography or are composed of nano-sized materials. These materials have a size range between 1 and 100 nm (109m) Nanotechnology often involves onedimensional concepts (nano-dots and nano wires) or the self-assembly of more complex structures (nanotubes). Materials are also classified according to their form and structure as nanostructures, nanocrystals, nano coatings. b) Methods of Creating Nano-topography Nanotechnology requires novel ways of manipulating matter in the atomic scale. Several approaches are currently prevalent in the experimental application to endosseous implants.\par
1. One approach involves the physical method of compaction of nano-particles of TiO2 vs. micronlevel particles to yield surfaces with nano scale grain boundaries78. An advantage of this method is that it conserves the chemistry of the surface among different topographies. 2. Second is the process of molecular selfassembly. Self-assembled monolayers (SAMs) are formed by the spontaneous chemisorptions and vertical close-packed positioning of exposed functional end group could be an osteo inductive or cell adhesive molecule. An example of this is the use of cell adhesive peptide domains (RGD domains) appended to SAMs composed of poly ethylene glycol (PEG) and applied to the titanium implant surfaces. 3. A third method is the chemical treatment of different surfaces to expose reactive groups on the material surface and create nano-scale topography. This is popular among current dental implant investigators. NaOH treatment catalyzes the production of titanium nanostructures outward from the titanium surface79. 4. The deposition of nanoparticles on to the titanium surface represents a fourth approach to imparting nanofeatures to a titanium dental implant80 Solgel transformation techniques achieve deposition of nano meter-scale calcium phosphate accretions to the implant surface81-82. Alumina, Titania, zirconia and other materials can also be applied83. Owing to their resultant atomic-scale interactions, the accretions display strong physical interactions. a. In a modified approach, Nishimura and  colleagues [2007] demonstrated a directed approach to assembly of CaPO4 nano features on dual acid-etched cp Titanium implant surfaces. The deposition of discrete 20-40nm nanoparticles on an acid-etched titanium surface led to increased mechanical interlocking with bone and the early healing of bone at the endosseous implant surface in a rat model. One of the main concerns related to coating the implant surface is the risk of coating detachment and toxicity of related debris 84 . 5. A fifth approach to creating nano scale topography on Titanium is the use of optical methods (typically lithography) reliant on wave length specific dimensions to achieve the appropriate nano scale modification. These approaches are labor intensive methods that require considerable development prior to clinical translation. The present use of lasers to promote micron-level groove on an implant surface can produce micron-level, not nano scale, modification of the implant surface . Another method of depositing nano scale material on to the implant surface involves ion beam deposition (e.g. hydroxyapatite) \hyperref[b86]{85} .\par
X. 
\section[{Conclusion}]{Conclusion}\par
Implant surface characteristics are widely recognized as being of fundamental importance in achieving long-term implant success. As such, extensive research has been performed in order to determine the surface texture necessary to attain an optimal bone-implant biomechanical interlock. Four interrelated properties of an implant surface affect osteogenic activity: chemical composition, surface energy, surface roughness, and surface morphology.Osseointegration and its underlying mechanisms of cell attachment, migration, proliferation, and differentiation are sensitive to one or more of these properties. Methods of enhancing the implant surface include alteration of the microstructure and modification of its physiochemical parameters, including surface free energy and wettability.\par
The surface qualities are of utmost importance in establishing of a reaction between the implant and the tissues. This concerns the surface structure as well as its chemical and biological properties. Much attention has been focused on the importance of the macrostructure of the implants for establishing retention in the bone. More attention will probably be focused in the future on the biological effects of the surface structure on the microstructural and ultrastructural levels as well as on the surface chemistry of the implants. Progress in these fields based on knowledge of the biological effects may provide implants with improved tissue response and clinical performance in the future. \begin{figure}[htbp]
\noindent\textbf{}\includegraphics[]{image-2.png}
\caption{\label{fig_0}}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{23}\includegraphics[]{image-3.png}
\caption{\label{fig_1}Figure 2 :Figure 3 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{4}\includegraphics[]{image-4.png}
\caption{\label{fig_2}Figure 4 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{}\includegraphics[]{image-5.png}
\caption{\label{fig_3}}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{5}\includegraphics[]{image-6.png}
\caption{\label{fig_4}Figure 5 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{}\includegraphics[]{image-7.png}
\caption{\label{fig_5}}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{6}\includegraphics[]{image-8.png}
\caption{\label{fig_6}Figure 6 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{}\includegraphics[]{image-9.png}
\caption{\label{fig_7}}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{}\includegraphics[]{image-10.png}
\caption{\label{fig_8}}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{7}\includegraphics[]{image-11.png}
\caption{\label{fig_9}Figure 7 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{}\includegraphics[]{image-12.png}
\caption{\label{fig_11}}\end{figure}
     			\footnote{© 2014 Global Journals Inc. (US)} 		 		\backmatter  			  				\begin{bibitemlist}{1}
\bibitem[Macheras et al.]{b8}\label{b8} 	 		\textit{},  		 			G Macheras 		,  		 			D Mpaltas 		,  		 			A Kostakos 		,  		 			K Tsiamtsouris 		,  		 			S Koutsostathis 		,  		 			K 		.  	 	 		\textit{Kateros. and Traumatology}  		53 p. .  	 
\bibitem[Munisamy]{b57}\label{b57} 	 		\textit{},  		 			S Munisamy 		.  		 	 
\bibitem[ Int J Oral Maxillofac Implants ()]{b74}\label{b74} 	 		\textit{},  	 	 		\textit{Int J Oral Maxillofac Implants}  		2005. 20 p. .  	 
\bibitem[Vaidyanathan and Vaidyanathan ()]{b58}\label{b58} 	 		‘A Bone-Like Precoating Strategy For Implants: Collagen Immobilization And Its Mineralization On Pure Titanium Implant Surface’.  		 			T K Vaidyanathan 		,  		 			; J Vaidyanathan 		.  	 	 		\textit{Journal of Oral Implantology}  		2008. 34 p. .  	 
\bibitem[Lotzara et al. ()]{b62}\label{b62} 	 		‘A Human Histologie Anaiysis of Osseotite and Machined Surfaces Using impiants with 2 Opposing Surfaces’.  		 			Richard J Lotzara 		,  		 			Tiziano Testorf 		,  		 			Paolo Trisi 		,  		 			Stephan S Porter 		,  		 			Roberto L Weinstein 		.  	 	 		\textit{Int J Periodontics Restorative Dent}  		1999. 19 p. .  	 
\bibitem[Drummond et al. ()]{b60}\label{b60} 	 		‘A light and scanning electron microscopic evaluation of electrodischarge-compacted porous titanium implants in rabbit tibia’.  		 			J F Drummond 		,  		 			J T Dominici 		,  		 			P J Sammon 		,  		 			K Okazaki 		,  		 			R Geissler 		,  		 			M I Lifland 		.  	 	 		\textit{J Oral Implantol}  		1995. 21 p. .  	 
\bibitem[Swope and James ()]{b37}\label{b37} 	 		‘A longitudinal study on hemidesmosome formation at the dental implant-tissue overflow’.  		 			E M Swope 		,  		 			R A James 		.  	 	 		\textit{J Oral Implantol}  		1981. 9 p. .  	 
\bibitem[Giordano et al. ()]{b12}\label{b12} 	 		‘A new chemical etching process to improve endosseous implant osseointegration: In vitro evaluation on human osteoblast-like cells’.  		 			C Giordano 		,  		 			E Sandrini 		,  		 			V Busini 		,  		 			R Chiesa 		,  		 			G Fumagalli 		,  		 			G Giavaresi 		.  	 	 		\textit{Int J Artif Organs}  		2006. 29 p. .  	 
\bibitem[Ellingsen (1991)]{b24}\label{b24} 	 		‘A study on the mechanism of protein adsorption to TiO2’.  		 			J E Ellingsen 		.  	 	 		\textit{Biomaterials}  		1991 Aug. 12  (6)  p. .  	 
\bibitem[Gotfredsen et al. ()]{b20}\label{b20} 	 		‘Anchorage of TiO2-blasted,HA-coated and machined implants : an experimental study with rabbits’.  		 			K Gotfredsen 		,  		 			A Wennerberg 		,  		 			C Johansson 		,  		 			L T Skovgaard 		,  		 			E Hjorting-Hansen 		.  	 	 		\textit{J Biomed Mater Res}  		1995. 29 p. .  	 
\bibitem[Kim et al. ()]{b83}\label{b83} 	 		‘Bioactive macro porous titanium surface layer on titanium substrate’.  		 			H M Kim 		,  		 			T Kokubo 		,  		 			S Fujibayashi 		,  		 			S Nishiguchi 		,  		 			T Nakamura 		.  	 	 		\textit{J Biomed Mater Res}  		2000. 5  (52)  p. .  	 
\bibitem[Schliephake et al. (2003)]{b42}\label{b42} 	 		‘Biological performance of biomimetic calcium phosphate coating of titanium implants in the dog mandible’.  		 			H Schliephake 		,  		 			D Scharnweber 		,  		 			M Dard 		,  		 			S Röbetaler 		,  		 			A Sewing 		,  		 			C Hüttmann 		.  	 	 		\textit{J Biomed Mater Res A}  		2003 Feb 1. 64  (2)  p. .  	 
\bibitem[Reyes et al. (2007)]{b41}\label{b41} 	 		‘Biomolecular surface coating to enhance orthopaedic tissue healing and integration’.  		 			Catherine D Reyes 		,  		 			Timothy A Petrie 		,  		 			Kellie L Burns 		,  		 			Zvi Schwartz 		,  		 			Andrés J García 		.  	 	 		\textit{Biomaterials}  		2007 July. 28  (21)  p. .  	 
\bibitem[Chen et al. (2004)]{b50}\label{b50} 	 		‘Bone morpho-genetic proteins’.  		 			D Chen 		,  		 			M Zhao 		,  		 			G R Mundy 		.  	 	 		\textit{Growth Factors}  		2004 Dec. 22  (4)  p. .  	 
\bibitem[Teixeira and Urist ()]{b47}\label{b47} 	 		‘Bone morphogenetic protein induced repair of compartmentalized segmental diaphyseal defects’.  		 			J O Teixeira 		,  		 			M R Urist 		.  	 	 		\textit{Arch Orthop Trauma Surg}  		1998. 117  (1-2)  p. .  	 
\bibitem[Bessa et al. ()]{b31}\label{b31} 	 		‘Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts)’.  		 			P C Bessa 		,  		 			M Casal 		,  		 			R L Reis 		.  	 	 		\textit{J Tissue Eng Regen Med}  		2008. 2 p. .  	 
\bibitem[Bessa et al. ()]{b32}\label{b32} 	 		‘Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part II (BMP delivery)’.  		 			P C Bessa 		,  		 			M Casal 		,  		 			R L Reis 		.  	 	 		\textit{J Tissue Eng Regen Med}  		2008. 2 p. .  	 
\bibitem[Larsson et al. ()]{b16}\label{b16} 	 		‘Bone response to surface-modified titanium implants: studies on the early tissue response to machined and electropolished implants with different oxide thicknesses’.  		 			C Larsson 		,  		 			P Thomsen 		,  		 			B. -O Aronsson 		,  		 			M Rodahl 		,  		 			J Lausmaa 		,  		 			B Kasemo 		.  	 	 		\textit{Biomaterials}  		1996. 17 p. .  	 
\bibitem[Reddi (1995)]{b48}\label{b48} 	 		‘Cartilage morphogenesis: role of bone and cartilage morphogenetic proteins, homeobox genes and extracellular matrix’.  		 			A H Reddi 		.  	 	 		\textit{Matrix Biol}  		1995 Oct. 14  (8)  p. .  	 
\bibitem[Gagnon ()]{b26}\label{b26} 	 		‘Ceramic hydroxyapatite: A new dimension in chromatography of biological molecules’.  		 			P Gagnon 		.  	 	 		\textit{Calif Technical Bulletin \#2156},  				 (Hercules)  		1996.  	 
\bibitem[Lausmaa et al. ()]{b17}\label{b17} 	 		‘Chemical Composition and Morphology of Titanium Surface Oxides’.  		 			J Lausmaa 		,  		 			L Mattsson 		,  		 			U Rolander 		,  		 			B Kasemo 		.  	 	 		\textit{Mat Res Soc Symp Proc}  		1986. 55 p. .  	 
\bibitem[Bernardi and Kawasaki (1968)]{b25}\label{b25} 	 		‘Chromatography of polypeptides and proteins on hydroxyapatite columns’.  		 			G Bernardi 		,  		 			T Kawasaki 		.  	 	 		\textit{Biochim Biophys Acta}  		1968 Aug 13. 160  (3)  p. .  	 
\bibitem[Rammelt et al. (2006)]{b40}\label{b40} 	 		‘Coating of titanium implants with collagen, RGD peptide and chondroitin sulfate’.  		 			S Rammelt 		,  		 			T Illert 		,  		 			S Bierbaum 		,  		 			D Scharnweber 		,  		 			H Zwipp 		,  		 			W Schneiders 		.  	 	 		\textit{Biomaterials}  		2006 Nov. 27  (32)  p. .  	 
\bibitem[Massaro et al. ()]{b64}\label{b64} 	 		‘Comparative investigation of the surface of commercial titanium dental implants. Part 1: chemical composition’.  		 			C Massaro 		,  		 			F Rotolo 		,  		 			De Riccardis 		,  		 			F Milella 		,  		 			E Napoli 		,  		 			A Wieland 		,  		 			M 		.  	 	 		\textit{J Mater Sci Mater Med}  		2002. 13 p. .  	 
\bibitem[Aparicio et al. ()]{b63}\label{b63} 	 		\textit{Corrosion behavior of commercially pure titanium shot blasted with different materials and size of shot particles for dental implant applications},  		 			C Aparicio 		,  		 			F J Gil 		,  		 			C Fonseca 		,  		 			M Barbosa 		,  		 			J A Planell 		.  		Biomaterials2003. 24 p. .  	 
\bibitem[Blom et al. (1998)]{b51}\label{b51} 	 		‘Cortical bone ingrowth in growth hormone-loaded grooved implants with calcium phosphate coatings in goat femurs’.  		 			E J Blom 		,  		 			J G Verheij 		,  		 			J M De Blieck-Hogervorst 		,  		 			Di Silvio 		,  		 			L Klein 		,  		 			CP 		.  	 	 		\textit{Biomaterials}  		1998 Jan-Feb;19.  (1-3)  p. .  	 
\bibitem[Hay and Moreno ()]{b6}\label{b6} 	 		‘Differential adsorption and chemical affinities of proteins for apatitic surfaces’.  		 			D I Hay 		,  		 			E C Moreno 		.  	 	 		\textit{J Dent Res}  		1979. 58 p. .  	 
\bibitem[Schwartz et al. (1993)]{b14}\label{b14} 	 		‘Direct effects of transforming growth factor-beta on chondrocytes are modulated by vitamin D metabolites in a cell maturation-specific manner’.  		 			Z Schwartz 		,  		 			L F Bonewald 		,  		 			K Caulfield 		,  		 			B Brooks 		,  		 			B D Boyan 		.  	 	 		\textit{Endocrinology}  		1993 Apr. 132  (4)  p. .  	 
\bibitem[Nishimura et al. ()]{b85}\label{b85} 	 		‘Discrete deposition of hydroxyl-apatite nano particles on titanium implant with predisposing substrate micro topography accelerated osseointegration’.  		 			I Nishimura 		,  		 			Y Huang 		,  		 			F Butz 		,  		 			T Ogawa 		,  		 			L Lin 		,  		 			Jake Wang 		,  		 			C 		.  	 	 		\textit{Nanotechnology}  		2007. 18 p. .  	 
\bibitem[Klokkevold et al. ()]{b66}\label{b66} 	 		‘Early endosseous integration enhanced by dual acid etching of titanium: a torque removal study in the rabbit’.  		 			Perry R Klokkevold 		,  		 			Paul Johnson 		,  		 			Soheila Dadgostari 		,  		 			John E Davies 		,  		 			Angelo 		.  	 	 		\textit{Clin. Oral Impl. Res}  		2001. 12 p. .  	 
\bibitem[Michael et al. ()]{b70}\label{b70} 	 		‘Early Loading at 21 Days of Non-Submerged Titanium Implants With a Chemically Modified Sandblasted and Acid-Etched Surface: 3-Year Results of a Prospective Study in the Posterior Mandible’.  		 			M Michael 		,  		 			Julia-Gabriela Bornstein 		,  		 			Urs Wittneben 		,  		 			Daniel Brägger 		,  		 			Buser 		.  	 	 		\textit{J Periodontol}  		2010. 81 p. .  	 
\bibitem[Yamazaki et al. (1996)]{b45}\label{b45} 	 		‘Ectopic induction of cartilage and bone by bovine bone morphogenetic protein using a biodegradable polymeric reservoir’.  		 			Y Yamazaki 		,  		 			S Oida 		,  		 			K Ishihara 		,  		 			N Nakabayashi 		.  	 	 		\textit{J Biomed Mater Res}  		1996 Jan. 30  (1)  p. .  	 
\bibitem[Giavaresi et al. ()]{b34}\label{b34} 	 		‘Effect of a Multiphasic Anodic Spark Deposition Coating on the Improvement of Implant Osseointegration in the Osteopenic Trabecular Bone of Sheep’.  		 			Gianluca Giavaresi 		,  		 			Roberto Chiesa 		,  		 			Milena Fini 		,  		 			Enrico Sandrini 		.  	 	 		\textit{Int J Oral Maxillofac Implants}  		2008. 23 p. .  	 
\bibitem[Anselme et al. ()]{b77}\label{b77} 	 		‘Effect of grooved titanium substratum on human osteoblastic cell growth’.  		 			K Anselme 		,  		 			M Bigerelle 		,  		 			B Noel 		,  		 			A Lost 		,  		 			P Hardouin 		.  	 	 		\textit{J Biomed Mater}  		Res2002. 60 p. .  	 
\bibitem[Schliephake et al. ()]{b39}\label{b39} 	 		‘Effect of immobilized bone morphogenic protein 2 coating of titanium implants on peri-implant bone formation’.  		 			H Schliephake 		,  		 			A Aref 		,  		 			D Scharnweber 		,  		 			S Bierbaum 		,  		 			S Roessler 		,  		 			A Sewing 		.  	 	 		\textit{Clin Oral Implants Res}  		2005. 16 p. .  	 
\bibitem[Shteyer et al.]{b29}\label{b29} 	 		‘Effect of local application of fluoride on healing of experimental bone fractures in rabbits’.  		 			R Shteyer 		,  		 			A Liberman 		,  		 			I Simkin 		,  		 			Gedalia 		.  		 \xref{http://dx.doi.org/10.1007/BF02010368}{10.1007/BF02010368}.  	 	 		\textit{Calcified Tissue International}  		22  (1)  p. .  	 
\bibitem[Foley et al. ()]{b67}\label{b67} 	 		‘Effect of phosphate treatment of Acid-etched implants on mineral apposition rates near implants in a dog model’.  		 			Christine Foley 		,  		 			? Hyon 		,  		 			Kerns 		,  		 			G ? David 		,  		 			Hallmon 		,  		 			W ? William 		,  		 			Rivera-Hidalgo 		,  		 			? Francisco 		,  		 			Carl J ? Nelson 		,  		 			Robert Spears 		.  	 	 		\textit{Int J Maxillofac Implants}  		2010. 25 p. .  	 
\bibitem[Att et al. ()]{b76}\label{b76} 	 		‘Effect of Titanium Surface Characteristics on the Behavior and Function of Oral Fibroblasts Int’.  		 			Wael Att 		,  		 			Masahiro Yamada 		,  		 			Takahiro Ogawa 		.  	 	 		\textit{J Oral Maxillofac Implants}  		2009. 24 p. .  	 
\bibitem[Martin et al. (1995)]{b11}\label{b11} 	 		‘Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63)’.  		 			J Y Martin 		,  		 			Z Schwartz 		,  		 			T W Hummert 		,  		 			D M Schraub 		,  		 			J Simpson 		,  		 			J LankfordJr 		.  	 	 		\textit{J Biomed Mater Res}  		1995 Mar. 29  (3)  p. .  	 
\bibitem[Buser et al. ()]{b68}\label{b68} 	 		‘Enhanced Bone Apposition to a Chemically Modified SLA Titanium Surface’.  		 			D Buser 		,  		 			N Broggini 		,  		 			M Wieland 		,  		 			R K Schenk 		,  		 			A J Denzer 		,  		 			D L Cochran 		.  	 	 		\textit{J Dent Res}  		2004. 83  (7)  p. .  	 
\bibitem[Buser et al. ()]{b69}\label{b69} 	 		‘Enhanced Bone Apposition to a Chemically Modified SLA Titanium Surface’.  		 			D Buser 		,  		 			N Broggini 		,  		 			M Wieland 		,  		 			R K Schenk 		,  		 			A J Denzer 		,  		 			D L Cochran 		,  		 			B Hoffmann 		.  	 	 		\textit{J Dent Res}  		2004. 83  (7)  p. .  	 
\bibitem[Fuerst ()]{b53}\label{b53} 	 		‘Enhanced bone to implant contact by plateletreleasedgrowth factors in mandibular cortical bone: a histomorpho-metricstudy in minipigs’.  		 			G Fuerst 		.  	 	 		\textit{Int. J. Oral Maxillofac. Implants}  		2003. 18 p. .  	 
\bibitem[Eduardo and Anitua ()]{b54}\label{b54} 	 		‘Enhancement of osseointegration by developing a dynamic implant surface’.  		 			A Eduardo 		,  		 			Anitua 		.  	 	 		\textit{Journal of oral implantology}  		2006. 32  (2)  p. .  	 
\bibitem[Coelho and Suzuki ()]{b86}\label{b86} 	 		‘Evaluation of an IBAD TH infilm process as an alternative method for surface in corporation of bioceramics on dental implants. A study in dogs’.  		 			P G Coelho 		,  		 			M Suzuki 		.  	 	 		\textit{J Appl Oral Sci}  		2005. 13 p. .  	 
\bibitem[Stadlinger et al. (2007)]{b49}\label{b49} 	 		‘Evaluation of osseoint-egration of dental implants coated with collagen, chondroitin sulphate and BMP-4: an animal study’.  		 			B Stadlinger 		,  		 			E Pilling 		,  		 			M Huhle 		,  		 			R Mai 		,  		 			S Bierbaum 		,  		 			D Scharnweber 		.  	 	 		\textit{Int J Oral Maxillofac Surg}  		2008 Jan. 2007 Nov 5. 37  (1)  p. .  	 
\bibitem[Brunette ()]{b3}\label{b3} 	 		‘Fibroblasts on micromachined substrata orient hierarchically to grooves of different dimensions’.  		 			D M Brunette 		.  	 	 		\textit{Exp Cell Res}  		1986. 164  (1)  p. .  	 
\bibitem[Dean et al. (1995)]{b36}\label{b36} 	 		‘Fibronectin and laminin enhance gingival cell attachment to dental implant surfaces in vitro’.  		 			J W Dean 		,  		 			K C Culbertson 		,  		 			D' Angelo 		,  		 			AM 		.  	 	 		\textit{Int J Oral Maxillofac Implants}  		1995 Nov-Dec. 10  (6)  p. .  	 
\bibitem[Glossary of Periodontal Terms American Academy of Periodontology ()]{b0}\label{b0} 	 		‘Glossary of Periodontal Terms’.  	 	 		\textit{American Academy of Periodontology}  		2001. p. 27.  	 	 (Implant) 
\bibitem[De Maeztu et al. ()]{b71}\label{b71} 	 		‘Histomorphometric Study of Ion Implantation and Diamond-like Carbon as Dental Implant Surface Treatments in Beagle Dogs’.  		 			Miguel A De Maeztu 		,  		 			Inigo Braceras Meng 		,  		 			J Inaki Alava 		,  		 			M Sanchez-Garces 		,  		 			Cosme Gay-Escoda 		.  	 	 		\textit{Int J Oral Maxillofac Implants}  		2007. 22 p. .  	 
\bibitem[Zhou et al. ()]{b80}\label{b80} 	 		‘Hydrogels prepared from unsubstituted cellulose in NaOH/urea aqueous solution’.  		 			J Zhou 		,  		 			C Chang 		,  		 			R Zhang 		,  		 			L Zhang 		.  	 	 		\textit{Macromol Biosci}  		2007. 7 p. .  	 
\bibitem[Hydroxyapatite-coated dental implants Dent Clin North America ()]{b30}\label{b30} 	 		‘Hydroxyapatite-coated dental implants’.  	 	 		\textit{Dent Clin North America}  		1992. 36 p. .  	 
\bibitem[Lee et al. ()]{b84}\label{b84} 	 		‘Hydroxyapatite-TiO2 hybrid coating on Ti implants’.  		 			S H Lee 		,  		 			H W Kim 		,  		 			E J Lee 		,  		 			Lil H Kim 		,  		 			HE 		.  	 	 		\textit{J Biomater Appl}  		2006. 20 p. .  	 
\bibitem[Shalabi et al. ()]{b72}\label{b72} 	 		‘Implant Surface Roughness and Bone Healing: a Systematic Review’.  		 			M M Shalabi 		,  		 			A Gortemaker 		,  		 			M A Van't Hof 		,  		 			J A Jansen 		,  		 			N H J Creugers 		.  	 	 		\textit{J Dent Res}  		2006. 85  (6)  p. .  	 
\bibitem[Puleo and Thomas ()]{b7}\label{b7} 	 		‘Implant Surfaces’.  		 			David A Puleo 		,  		 			Mark V Thomas 		.  	 	 		\textit{Dent. Clin. North America}  		2006. 50 p. .  	 
\bibitem[Zellin and Linde (1997)]{b46}\label{b46} 	 		‘Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects’.  		 			G Zellin 		,  		 			A Linde 		.  	 	 		\textit{J Biomed Mater Res}  		1997 May. 35  (2)  p. .  	 
\bibitem[Story et al. ()]{b61}\label{b61} 	 		‘In vivo performance of a modified CS Ti dental implant coating’.  		 			B J Story 		,  		 			W R Wagner 		,  		 			D M Gaisser 		,  		 			S D Cook 		,  		 			A M Rust-Dawicki 		.  	 	 		\textit{Int J Oral Maxillofac Implants}  		1998. 13 p. .  	 
\bibitem[Webster and Ejiofor ()]{b79}\label{b79} 	 		\textit{Increased osteoblast adhesion on nanophase metals: Ti, Ti6Al4V, and CoCrMo},  		 			T J Webster 		,  		 			J Ejiofor 		.  		Biomaterials2004. 25 p. .  	 
\bibitem[Damen et al. ()]{b23}\label{b23} 	 		‘Induction of Calcium Phosphate Precipitation by Titanium Dioxide’.  		 			J J M Damen 		,  		 			J M Cate 		,  		 			J E Ellingsen 		.  	 	 		\textit{J Dent Res}  		1991. 70  (10)  p. .  	 
\bibitem[Buser et al. ()]{b19}\label{b19} 	 		‘Influence of surface characteristics on bone integration of Titanium implants. A Histomorphometric study in Miniature pigs’.  		 			D Buser 		,  		 			R Schenk 		,  		 			S Steinemann 		,  		 			J Fiorellini 		,  		 			C Fox 		,  		 			H Stich 		.  	 	 		\textit{J Biomed Mater Res}  		1991. 25 p. .  	 
\bibitem[Clemow et al. ()]{b9}\label{b9} 	 		‘Interface mechanics of porous titanium implants’.  		 			A J Clemow 		,  		 			A Weinstein 		,  		 			J Klawitter 		,  		 			J Koeneman 		,  		 			J Anderson 		.  		 \xref{http://dx.doi.org/10.1002/jbm.820150111}{10.1002/jbm.820150111}.  	 	 		\textit{Journal of Biomedical Materials Research}  		1981. 15 p. .  	 
\bibitem[Stefani et al. ()]{b52}\label{b52} 	 		‘Jr Platelet-derived growth factor/insulin-like growth factor-1 combination and bone regeneration around implants placed into extraction sockets: a histometric study in dogs’.  		 			C M Stefani 		,  		 			M A Machado 		,  		 			E A Sallum 		,  		 			A W Sallum 		,  		 			S Toledo 		,  		 			F H Nociti 		.  	 	 		\textit{Implant Dent}  		2000. 9  (2)  p. .  	 
\bibitem[Predecki et al. ()]{b10}\label{b10} 	 		‘Kinetics of bone growth into cylindrical channels in aluminum oxide and titanium’.  		 			Predecki 		,  		 			J Stephan 		,  		 			B Auslaender 		,  		 			V L Mooney 		,  		 			K Kirkland 		.  		 \xref{http://dx.doi.org/10.1002/jbm.820060506}{10.1002/jbm.820060506}.  	 	 		\textit{Journal of Biomedical Materials Research}  		1972. 6 p. .  	 
\bibitem[Aladino De Ranieri et al. ()]{b55}\label{b55} 	 		‘Local application of rhTGF-h2 modulates dynamic gene expression in a rat implant model’.  		 			Amarjit S Aladino De Ranieri 		,  		 			Shinji Virdi 		,  		 			Susan Kuroda 		,  		 			Yang Shottc 		,  		 			Dale R Dai 		,  		 			Sumner 		.  	 	 		\textit{Bone}  		2005. 36 p. .  	 
\bibitem[Lifland et al. ()]{b59}\label{b59} 	 		‘Mechanical properties of a Ti-6A1-4Vdental implant produced by electro-discharge compaction’.  		 			M I Lifland 		,  		 			D K Kim 		,  		 			K Okazaki 		.  	 	 		\textit{Clin Mater}  		1993. 14 p. .  	 
\bibitem[Baud et al. (1977)]{b27}\label{b27} 	 		‘Minor elements in bone mineral and their effects on its solubility’.  		 			C A Baud 		,  		 			S Bang 		,  		 			J M Very 		.  	 	 		\textit{J Biol Buccale}  		1977 Sep. 5  (3)  p. .  	 
\bibitem[Sul et al.]{b73}\label{b73} 	 		\textit{Optimum Surface Properties of Oxidized Implants for Reinforcement of Osseointegration: Surface Chemistry, Oxide Thickness, Porosity, Roughness},  		 			Young-Taeg Sul 		,  		 			Carina Johansson 		,  		 			Ann Wennerberg 		,  		 			Lee-Ra Cho 		,  		 			Beom-Seok Chang 		,  		 			Tomas Albrektsson 		.  		 	 	 (and Crystal Struc-ture) 
\bibitem[Albrektsson and Wennerberg ()]{b18}\label{b18} 	 		‘Oral Implant Surfaces: Part 1-Review Focusing on Topographic and Chemical Properties of Different Surfaces and In Vivo Responses to them’.  		 			Tomas Albrektsson 		,  		 			Ann Wennerberg 		.  	 	 		\textit{Int j prosthodont}  		2004. 17 p. .  	 
\bibitem[De Jonge et al. (2008)]{b44}\label{b44} 	 		‘Organic-inorganic surface modific-ations for titanium implant surfaces’.  		 			L T De Jonge 		,  		 			S C Leeuwenburgh 		,  		 			J G Wolke 		,  		 			J A Jansen 		.  	 	 		\textit{Pharm Res}  		2008 Oct. 25  (10)  p. .  	 
\bibitem[De Jonge et al. (2008)]{b2}\label{b2} 	 		‘Organic-Inorganic Surface Modifications for Titanium Implant Surfaces’.  		 			Lise T De Jonge 		,  		 			C G Sander 		,  		 			Leeuwenburgh 		,  		 			G C Joop 		,  		 			John A Wolke 		,  		 			Jansen 		.  		 \xref{http://dx.doi.org/10.1007/s11095-008-9617-0}{10.1007/s11095-008-9617-0}.  	 	 		\textit{Pharmaceutical Research}  		2008. October 2008.  (10) .  	 	 (25Vol. 25) 
\bibitem[Park et al. (2006)]{b56}\label{b56} 	 		‘Osseointegration of anodized titanium implants coated with fibroblast growth factor-fibronectin (FGF-FN) fusion protein’.  		 			J M Park 		,  		 			J Y Koak 		,  		 			J H Jang 		,  		 			C H Han 		,  		 			S K Kim 		,  		 			S J Heo 		.  	 	 		\textit{Int J Oral Maxillofac Implants}  		2006 Nov-Dec;21.  (6)  p. .  	 
\bibitem[Boyan et al. ()]{b15}\label{b15} 	 		‘Osteoblasts Generate An Osteogenic Microenvironment When Grown On Surfaces With Rough Microtopographies’.  		 			B D Boyan 		,  		 			S Lossdörfer 		,  		 			L Wang 		,  		 			G Zhao 		,  		 			C H Lohmann 		,  		 			D L Cochran 		.  	 	 		\textit{European Cells and Materials}  		2003. 6 p. .  	 
\bibitem[Bernhardt et al. (2006)]{b38}\label{b38} 	 		‘Osteoconductive modifications of Ti-implants in a goat defect model: characterization of bone growth with SR muCT and histology’.  		 			R Bernhardt 		,  		 			J Van Den Dolder 		,  		 			S Bierbaum 		,  		 			R Beutner 		,  		 			D Scharnweber 		,  		 			J Jansen 		.  	 	 		\textit{Biomaterials}  		2006 Feb. 27  (4)  p. 670.  	 
\bibitem[Hahn ()]{b33}\label{b33} 	 		‘Palich Preliminary evaluation of porous metal surfaced titanium for orthopedic implants’.  		 			H Hahn 		,  		 			W 		.  	 	 		\textit{Journal of Biomedical Materials Rese-arch}  		1970. 4 p. .  	 
\bibitem[Schwartz et al. ()]{b13}\label{b13} 	 		‘Production of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by growth zone and resting zone chondrocytes is dependent on cell maturation and is regulated by hormones and growth factors’.  		 			Z Schwartz 		,  		 			Brooks 		,  		 			Del Swain 		,  		 			A Toro 		,  		 			B Norman 		,  		 			Boyan 		.  	 	 		\textit{Endocrinology}  		1990. 130 p. .  	 
\bibitem[Persson et al. ()]{b78}\label{b78} 	 		‘Re-osseointegration after treatment of periimplantitis at different implant surfaces. An experimental study in the dog’.  		 			L G Persson 		,  		 			T Berglundh 		,  		 			J Lindhe 		,  		 			L Sennerby 		.  	 	 		\textit{Clin Oral Implants Res}  		2001. 12 p. .  	 
\bibitem[Anderson et al. ()]{b28}\label{b28} 	 		‘Response of cortical bone to local controlled release of sodium fluoride: The effect of implant insertion site’.  		 			P Anderson 		,  		 			J Copenhaver 		,  		 			A F Tencer 		,  		 			J M Clark 		.  		 \xref{http://dx.doi.org/10.1002/jor.1100090616}{10.1002/jor.1100090616}.  	 	 		\textit{Journal of Orthopaedic Research}  		1991. 9 p. .  	 
\bibitem[Ben-Nissan and Choi ()]{b81}\label{b81} 	 		‘Sol-gel production of bioactive nano coatings for medical applications. Part 1: An Introduction’.  		 			B Ben-Nissan 		,  		 			A Choi 		.  	 	 		\textit{Nano med}  		2006. 1 p. .  	 
\bibitem[Eirik Ellingsen (2000 1998)]{b1}\label{b1} 	 		‘Surface configurations of dental implants’.  		 			Jan Eirik Ellingsen 		.  	 	 		\textit{Periodontology}  		2000 1998. 17 p. .  	 
\bibitem[Gu´ehennec et al. (20007)]{b65}\label{b65} 	 		‘Surface treatments of titanium dental Implants for rapid osseointegration’.  		 			L Le Gu´ehennec 		,  		 			A Soueidan 		,  		 			P Layrolle 		,  		 			Y Amouriq 		.  	 	 		\textit{Dental materials}  		20007. 23 p. .  	 
\bibitem[Sul et al. (2005)]{b75}\label{b75} 	 		‘The bone response of oxidized bioactive and nonbioactive titanium implants’.  		 			Y T Sul 		,  		 			C Johansson 		,  		 			E Byon 		,  		 			T Albrektsson 		.  	 	 		\textit{Biomaterials}  		2005 Nov. 26  (33)  p. .  	 
\bibitem[Best et al. (1997)]{b22}\label{b22} 	 		‘The dependence of osteoblastic response on variations in the chemical composition and physical properties of hydroxyapatite’.  		 			S Best 		,  		 			B Sim 		,  		 			M Kayser 		,  		 			S Downes 		.  	 	 		\textit{J Mater Sci Mater Med}  		1997 Feb. 8  (2)  p. .  	 
\bibitem[Chappard et al. (1999)]{b43}\label{b43} 	 		‘The early remodeling phases around titanium implants: a histomorphometric assessment of bone quality in a 3-and 6-month study in sheep’.  		 			D Chappard 		,  		 			E Aguado 		,  		 			G Huré 		,  		 			F Grizon 		,  		 			M F Basle 		.  	 	 		\textit{Int J Oral Maxillofac Implants}  		1999 Mar-Apr. 14  (2)  p. .  	 
\bibitem[Albrektsson and Wennerberg ()]{b21}\label{b21} 	 		‘The impact of oral implants-past and future’.  		 			T Albrektsson 		,  		 			A Wennerberg 		.  	 	 		\textit{J Can Dent Assoc}  		1966-2042. 2005. 71 p. 327.  	 
\bibitem[Clark et al. ()]{b4}\label{b4} 	 		‘Topographical control of cell behaviour. I. Simple step cues’.  		 			P Clark 		,  		 			P Connolly 		,  		 			A S Curtis 		,  		 			J A Dow 		,  		 			C D Wilkinson 		.  	 	 		\textit{Development}  		1987. 99  (3)  p. .  	 
\bibitem[Clark et al. ()]{b5}\label{b5} 	 		‘Topographical control of cell behaviour: II. Multiple grooved substrata’.  		 			P Clark 		,  		 			P Connolly 		,  		 			A S G Curtis 		,  		 			J A T Dow 		,  		 			C D W Wilkinson 		.  	 	 		\textit{Development}  		1990. 108 p. .  	 
\bibitem[Puleo ()]{b35}\label{b35} 	 		‘Understanding and controlling the bone implant interface’.  		 			D A Puleo 		,  		 			NanciA 		.  	 	 		\textit{Biomaterials}  		1999. 20 p. .  	 
\bibitem[Liu et al. ()]{b82}\label{b82} 	 		‘Water-based solgel synthesis of hydroxy-apatite: process development’.  		 			D M Liu 		,  		 			T Troczynski 		,  		 			W Tseng 		.  	 	 		\textit{Biomaterials}  		2001. 22 p. .  	 
\end{bibitemlist}
 			 		 	 
\end{document}
